Majority of Canadians oppose longer drug patents in Canada–EU trade deal

Page content

Council of Canadians | Click HERE to read article

Nearly two-thirds of Canadians (65 per cent) oppose longer patents for prescription drugs in the proposed Canada–European Comprehensive Economic and Trade Agreement (CETA), according to an Environics poll commissioned by the Council of Canadians. Even among people who otherwise “strongly support” the idea of a free trade agreement with the EU, more than half (54 per cent) oppose a deal that extends patents on brand name drugs.